|Cancer Research Wire|
Cancer research news for the public and news media. More stories can be found at the Newswise Cancer News Source.
States with robust tobacco control policies and regulations, such as smoke free air laws and taxes on cigarettes, not only have fewer cigarette users but also fewer e-cigarette users, according to research from NYU School of Medicine and the NYU Coll...
– New York University
Nicotine & Tobacco Research; P50HL120163; 1K24DA038345-01; UL1TR000038 Embargo expired on 27-Feb-2018 at 07:00 ET
SBP researchers have developed the first ever high-throughput, genome-scale imaging-based approach to investigate protein stability. The method has been used to identify several previously unknown human proteins that HIV degrades to enhance its infec...
– Sanford Burnham Prebys Medical Discovery Institute
Cell Reports.; P01 AI090935; R01 AI124843; R01 AI105184; R01 AI127302, ; P01 CA177322 Embargo expired on 27-Feb-2018 at 12:00 ET
Value in Health, the official journal of ISPOR (the professional society for health economics and outcomes research), announced today the publication of new research suggesting that, on average, most women were willing to accept the risk of unnecessa...
– ISPOR—The Professional Society for Health Economics and Outcomes Research
Value in Health, Feb-2018
For years, researchers have attempted to harness the full potential of gene therapy, a technique that inserts genes into a patient’s cells to treat cancer and other diseases. However, inserting engineered DNA molecules into cells is difficult. A te...
– Washington University in St. Louis
Innovation and progress in cancer research and care are the result of collaboration and resources. This advancement also extends to cancer prevention and education, but more emphasis on these areas is needed -- especially when it comes to colorectal...Expert Available
– Rutgers Cancer Institute of New Jersey
Data from a new study led by University of Kentucky Markey Cancer Center researchers shows that repurposing drugs used to treat leukemia has promise for preventing melanoma metastasis.
– University of Kentucky
A team of Sandia National Laboratories researchers has designed and synthesized metal-organic framework nanoparticles that glow red or near infrared for at least two days in cells. This could prove useful in tracking the spread of cancer cells.
– Sandia National Laboratories
ACS Applied Materials and Interfaces
A heating and freezing process known as dual thermal ablation can kill pancreatic cancer cells, according to new research from Binghamton University, State University at New York.
– Binghamton University, State University of New York
Liver and Pancreatic Sciences, Nov-2017
Michelle Ozbun, PhD, is using two grants totaling $2.7 million to learn how human papillomaviruses (HPV) sneak into cells to reproduce. She and her team are also developing new ways in which to measure infections.
– University of New Mexico Comprehensive Cancer Center
The latest research, experts and features in Public Health in the Public Health News Source
The latest research and features in cell biology in the Cell Biology News Source
Advances in cancer treatment have resulted in a growing number of cancer survivors. However, powerful treatments such as chemotherapy, radiation treatments and some cancer drugs are not without their risks, including the potential for serious, long-t...
– Valley Health System
UCLA researchers found that nearly all people diagnosed with uveal melanoma had a number of unmet psychological and health information needs, particularly during the first three months after their diagnoses. The study is the first prospective, longit...
– University of California, Los Angeles (UCLA), Health Sciences
JAMA Ophthamalogy Feb 2018 Embargo expired on 22-Feb-2018 at 11:00 ET
Researchers have developed a highly-targeted and non-invasive drug-release method that combines a nanoscale gold particle-containing polymer coating and near-infrared light. The technology could also be used for other applications, including the seal...
– American Technion Society
ACS Applied Materials & Interfaces
Larotrectinib, a highly selective TRK kinase inhibitor, shows rapid, potent, and durable efficacy in both adult and pediatric patients with solid tumors that harbor TRK fusions, regardless of tumor type or patient age, according to results from three...
– Memorial Sloan Kettering Cancer Center
New England Journal of Medicine
Researchers at The University of Texas at Dallas have devised a new technique to isolate aggressive cells thought to form the root of many hard-to-treat metastasized cancers, a significant step toward developing new drugs that might target these cell...
– University of Texas at Dallas
Chemistry-A European Journal, Feb. 19, 2018
Three quarters of patients with a variety of advanced cancers occurring in different sites of the body responded to larotrectinib, a novel therapy that targets a specific genetic mutation. The oral treatment is based on the genetic traits of the tumo...
– Childrens Hospital Los Angeles
New England Journal of Medicine, Feb 21, 2018 Embargo expired on 21-Feb-2018 at 17:00 ET
Three simultaneous safety and efficacy studies of the drug larotrectinib reported an overall response rate of 75 percent for patients ages four months to 76 years with 17 different cancer diagnoses.
– University of Texas M. D. Anderson Cancer Center Embargo expired on 21-Feb-2018 at 17:00 ET
In what is believed to be the largest pancreatic cancer genome-wide association study to date, researchers at the Johns Hopkins Kimmel Cancer Center and the National Cancer Institute, and collaborators from over 80 other institutions worldwide discov...
– Johns Hopkins Medicine
Nature Communications; R01CA154823, HHSN26120080000IE, P50CA062924, R01CA97075
A team of artificial intelligence researchers developed a new deep-learning method to identify tumours in medical images.
– Centre hospitalier de l'Université de Montréal (CHUM)
Significant amounts of toxic metals, including lead, leak from some e-cigarette heating coils and are present in the aerosols inhaled by users, according to a study from scientists at Johns Hopkins Bloomberg School of Public Health.
– Johns Hopkins Bloomberg School of Public Health
Some scientists have hypothesized that tumor-promoting changes in cells during cancer development—particularly an epigenetic change involving DNA methylation—arise from rogue cells escaping a natural cell deterioration process called senescence. ...
– Johns Hopkins Medicine
Cancer Cell; R01CA185357, R21CA212495, R01CA170550
Myers has spent the last decade researching the prevalence, possible causes, management and treatment of chemo-brain.
– University of Kansas Cancer Center
Researchers describe the role of a transcription factor called TCF-1 in targeting the condensed chromatin and regulating the availability of genome sequences in T-cell development. The new connection between TCF-1 and chromatin will aid in developing...
– Perelman School of Medicine at the University of Pennsylvania
Immunity; NIH K22AI112570, R01AI047833, P01CA119070, NIH AI105343, AI082630, AI112521, AI115712, AI117718, AI108545, AI117950
New NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) for Cancer in People Living With HIV seek to reduce unnecessary, deadly cancer care gaps.
– National Comprehensive Cancer Network® (NCCN®) Embargo expired on 27-Feb-2018 at 09:00 ET
The National Comprehensive Cancer Network® (NCCN®) Oncology Research Program (ORP) announces the selection and implementation of the iEnvision medical affairs platform developed by Envision Technology Solutions.
– National Comprehensive Cancer Network® (NCCN®)
The GW Cancer Center recently welcomed 24 multidisciplinary health care teams from across the country to its inaugural TEAM (Together, Equitable, Accessible, Meaningful) Training program.
– George Washington University
Collaboration aims to accelerate next generation treatments in cancer, gastrointestinal diseases, and neurological disorders
– Fred Hutchinson Cancer Research Center
The University of Texas MD Anderson Cancer Center was awarded $22.3 million from the Cancer Prevention and Research Institute of Texas (CPRIT), accounting for 30 percent of the $73.5 million in awards CPRIT announced today. The awards included $16.3 ...
– University of Texas M. D. Anderson Cancer Center